sellWeak
Andrew Spaventa sold $16k of OMIC
Chief Executive Officer at Singular Genomics Systems, Inc.. 695 shares at an average of $22.55, traded Nov 12, 2024, filed Nov 13, 2024.
Warning score
20Value
$16k
695 shares
Holdings after
1,537
-31% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- 0Trade size$16k at market
- +10Share of holdings soldSold 31% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-126428, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 12, 2024 | MOption exercise Common Stock | +1,907 | - | - | 2,232 | Nov 13, 2024 |
| Nov 12, 2024 | SOpen-market sale Common Stock | -695 | $22.55 | $16k | 1,537 | Nov 13, 2024 |
| Nov 12, 2024 | GGift Common Stock | -1,212 | $0.00 | $0 | 325 | Nov 13, 2024 |
| Nov 12, 2024 | GGift Common Stockindirect: By The Andrew K. Spaventa Living Trust dated April 9, 2014 | +1,212 | $0.00 | $0 | 141,487 | Nov 13, 2024 |
| Nov 12, 2024 | MOption exercise Restricted Stock Unitsderivative | -1,907 | $0.00 | $0 | 24,780 | Nov 13, 2024 |
Related signals
Other insiders at Singular Genomics Systems, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | OMICsell Singular Genomics Systems, Inc. | Andrew Spaventa Chief Executive Officer | $3,629 180 shares | -22% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.